share_log

吉贝尔最新公告:第三季度净利润2059.91万元 同比下降38.18%

Gibel's latest announcement: net profit in the third quarter was 20.5991 million yuan, down 38.18% from the same period last year.

證券之星 ·  Oct 28, 2021 07:00

Giebel released a report for the third quarter of 2021 that operating income was 116 million yuan, down 27.44% from the same period last year; net profit belonging to shareholders of listed companies was 20.5991 million yuan, down 38.18% from the same period last year; net profit belonging to shareholders of listed companies after deducting non-recurring profits and losses was 17.4741 million yuan, down 43.68% from the same period last year; basic earnings per share was 0.11 yuan.

According to Gibel's quarterly report of 2021, the company's main income was 367 million yuan, down 8.97% from the same period last year; the net profit was 76.2487 million yuan, down 3.26% from the same period last year; and the non-net profit was 64.8424 million yuan, down 14.79% from the same period last year. Among them, in the third quarter of 2021, the company's main income in a single quarter was 116 million yuan, down 27.44% from the same period last year; net profit in a single quarter was 20.5991 million yuan, down 38.18% from the same period last year The non-net profit in a single quarter was 17.4741 million yuan, down 43.68% from the same period last year; the debt ratio was 11.29%, the investment income was 9.6834 million yuan, the financial expenses were-3.1102 million yuan, and the gross profit margin was 87.93%.

The stock has no agency rating in the last 90 days. In the past three months, the net outflow of financing was 9.6173 million, and the financing balance decreased; the net inflow of securities was 0, and the balance of securities lending increased. According to the Securities Star valuation analysis tool, Gibel (688566) has a good company rating of 3 stars, a good price rating of 1.5 stars, and a comprehensive valuation rating of 2 stars.

The chairman of the company is Geng Zhongyi. Mr. Geng Zhongyi: born in 1963, Chinese nationality, no permanent residence abroad, bachelor's degree, senior economist, licensed pharmacist, Mr. Geng Zhongyi has worked in Yancheng Pharmaceutical Company, Zhenjiang Pharmaceutical Industry Research Institute, Zhenjiang No. 3 Pharmaceutical Factory, Zhenjiang Yangtze River Sanitary products Factory, Zhenjiang second Pharmaceutical Factory, Zhenjiang Zhongtian Pharmaceutical Co., Ltd., served as technical director, factory director, general manager, chairman and other positions From November 2001 to September 2014, he served as chairman of Jiangsu Jibel Pharmaceutical Co., Ltd., and served as chairman and general manager of the company since September 2014. Mr. Geng Zhongyi personally participated in the research and development of many new drug projects of the company, applied for a number of invention patents related to nitrenolol tablets, antidepressants and other related inventions, and won the first prize of science and technology in Shanghai. it has been awarded as the advanced individual of scientific and technological cooperation in Zhenjiang, the scientific and technological pacesetter of Zhenjiang, the excellent scientific and technological worker in Zhenjiang, the training object of the first batch of "Science and Technology Entrepreneur training Project" in Jiangsu Province, Jiangsu Science and Technology Entrepreneur and other titles. He is also the executive director of China Pharmaceutical quality Management Association, the director of Jiangsu Medical quality Management Association, and the honorary chairman of Zhenjiang Pharmaceutical Association.

This article is compiled by the Securities Star data Center according to the public data and does not constitute investment opinions or suggestions. If there are any questions in the article, please contact us.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment